William Lewis, Director, Chair, and CEO, on April 06, 2026, sold 10,699 shares in Insmed (INSM) for $1,746,336. Following the Form 4 filing with the SEC, Lewis has control over a total of 535,109 common shares of the company, with 301,185 shares held directly and 233,924 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1104506/000140205126000022/xslF345X05/wk-form4_1775680879.xml
-- William Lewis, Director, Chair, and CEO, on April 06, 2026, sold 10,699 shares in Insmed (INSM) for $1,746,336. Following the Form 4 filing with the SEC, Lewis has control over a total of 535,109 common shares of the company, with 301,185 shares held directly and 233,924 controlled indirectly.
SEC Filing: